Strategic patterns for a defensible business
📈 Join 960+ life science executives who read my strategic insights every Friday at 11am ET.
What you'll get: Pattern analysis from 45+ founder interviews revealing what separates defensible businesses from science projects burning capital.
From a pharma-tech founder who learned hard lessons the hard way.
Trusted by leaders from Menarini, Merck, IQVIA, Medtronic, Flatiron Health, Debiopharm and 960+ more.
